Cryoport, Inc. (CYRX)

NASDAQ: CYRX · IEX Real-Time Price · USD
16.92
+0.95 (5.95%)
At close: Feb 27, 2024, 4:00 PM
16.57
-0.35 (-2.04%)
After-hours: Feb 27, 2024, 5:35 PM EST
5.95%
Market Cap 781.95M
Revenue (ttm) 236.35M
Net Income (ttm) -54.63M
Shares Out 48.96M
EPS (ttm) -1.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 430,884
Open 16.24
Previous Close 15.97
Day's Range 16.07 - 17.29
52-Week Range 9.00 - 24.30
Beta 1.57
Analysts Buy
Price Target 17.71 (+4.67%)
Earnings Date Mar 12, 2024

About CYRX

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to d... [Read more]

Sector Industrials
Founded 1999
Employees 1,000
Stock Exchange NASDAQ
Ticker Symbol CYRX
Full Company Profile

Financial Performance

In 2022, Cryoport's revenue was $237.28 million, an increase of 6.59% compared to the previous year's $222.61 million. Losses were -$45.33 million, -84.02% less than in 2021.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for CYRX stock is "Buy." The 12-month stock price forecast is $17.71, which is an increase of 4.67% from the latest price.

Price Target
$17.71
(4.67% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

NASHVILLE, Tenn. , Feb. 27, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in supply chain solutions for cell & gene therapies, today announced that the Company will report financ...

20 hours ago - PRNewsWire

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

Companies Will Partner to Provide Complete Supply Chain Solutions for the Life Science and Biopharmaceutical Industries NASHVILLE, Tenn. , Nov. 27, 2023 /PRNewswire/ -- Cryoport Inc. (Nasdaq: CYRX) ("...

3 months ago - PRNewsWire

Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express

CRYOPDP's Acquisition of Bluebird Express Adds Further Domestic and International Transportation Services Strengthening CRYOPDP's U.S. Logistics Operations NASHVILLE, Tenn. , Nov. 16, 2023 /PRNewswire...

3 months ago - PRNewsWire

Cryoport Reports Third Quarter 2023 Financial Results

Third quarter 2023 commercial Cell and Gene Therapy revenue up 54% year-over-year Supporting a record total of 670 clinical trials worldwide, with 81 in Phase 3 Nine months 2023 revenue of $176 millio...

3 months ago - PRNewsWire

Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition

Strategic Acquisition Strengthens Condition Monitoring Systems and Logistics Management Capabilities for the Biopharmaceutical Industry Throughout Cryoport's Family of Companies NASHVILLE, Tenn. , Nov...

4 months ago - PRNewsWire

Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023

NASHVILLE, Tenn. , Oct. 25, 2023 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing cell and...

4 months ago - PRNewsWire

Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF

NASHVILLE, Tenn. , Oct. 12, 2023 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing cell and...

4 months ago - PRNewsWire

Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies

Partnership Establishes Cryoport Systems' First U.K. Logistics Center to Support Future Expansion and Provide End-to-End Supply Chain Solutions for Advanced Therapy Manufacturers NASHVILLE, Tenn. and ...

5 months ago - PRNewsWire

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

Partnership will provide access to standardized and optimized apheresis collection, cryopreservation and bioprocessing processes throughout the U.S. and Europe MINNEAPOLIS and NASHVILLE, Tenn. , Oct. ...

5 months ago - PRNewsWire

Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award

Company Named "Best Cell & Gene Therapy Supplier – Cryogenic Storage" NASHVILLE, Tenn. , Sept. 14, 2023 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global pr...

5 months ago - PRNewsWire

The Law Offices of Frank R. Cruz Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Cryoport, Inc. (“Cryoport” or the “Company”) (NASDAQ: CYRX) on behalf of investors concerning the Company'...

6 months ago - Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Cryoport, Inc. (“Cryoport” or the “Company”)...

6 months ago - Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Cryoport, Inc. (“Cryoport” or the “Company”) (NASDAQ: CYRX) investors concerning the Company's p...

6 months ago - Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ...

6 months ago - Accesswire

Cryoport Reports Second Quarter 2023 Financial Results

Second quarter revenue of $57 million, in line with previously announced preliminary results Clinical trials supported by Cryoport increased to a record 668 global clinical trials by quarter end; a ne...

7 months ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cryoport, Inc. - CYRX

NEW YORK , Aug. 4, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or the "Company") (NASDAQ: CYRX). Such investors are advised to conta...

7 months ago - PRNewsWire

INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with LossesIn Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. (...

7 months ago - Accesswire

Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023

NASHVILLE, Tenn. , Aug. 2, 2023 /PRNewswire/ --  Cry oport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services for the fast growing cell a...

7 months ago - PRNewsWire

INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("...

7 months ago - Accesswire

INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("...

7 months ago - Accesswire

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("...

7 months ago - Accesswire

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("...

7 months ago - Accesswire

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $CYRX #CYRX--The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses to Contact the Firm.

8 months ago - Business Wire

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("...

8 months ago - Accesswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cryoport, Inc. (“...

8 months ago - Business Wire